{"id":"https://openalex.org/W4241160004","doi":"https://doi.org/10.1210/jcem.94.6.9996","title":"Pegylated Leptin Antagonist Is a Potent Orexigenic Agent: Preparation and Mechanism of Activity","display_name":"Pegylated Leptin Antagonist Is a Potent Orexigenic Agent: Preparation and Mechanism of Activity","publication_year":2009,"publication_date":"2009-06-01","ids":{"openalex":"https://openalex.org/W4241160004","doi":"https://doi.org/10.1210/jcem.94.6.9996"},"language":"en","primary_location":{"id":"doi:10.1210/jcem.94.6.9996","doi":"https://doi.org/10.1210/jcem.94.6.9996","is_oa":false,"landing_page_url":"https://doi.org/10.1210/jcem.94.6.9996","pdf_url":null,"source":{"id":"https://openalex.org/S205775358","display_name":"The Journal of Clinical Endocrinology & Metabolism","issn_l":"0021-972X","issn":["0021-972X","1945-7197"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-class-a","anvur-scientific","cwts-core","dongbi-b","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310311648","host_organization_name":"Oxford University Press","host_organization_lineage":["https://openalex.org/P4310311648","https://openalex.org/P4310311647"],"host_organization_lineage_names":["Oxford University Press","University of Oxford"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"The Journal of Clinical Endocrinology & Metabolism","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5082822020","display_name":"Eran Elinav","orcid":"https://orcid.org/0000-0002-5775-2110","observed_orcids":["https://orcid.org/0000-0002-5775-2110"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Eran Elinav","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5065277105","display_name":"Leonora Niv\u2010Spector","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Leonora Niv-Spector","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5103560898","display_name":"Meirav N. Katz","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Meirav Katz","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5057312279","display_name":"Tulin Otamis Price","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Tulin O. Price","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5100680450","display_name":"Mohammed Kumail Ali","orcid":"https://orcid.org/0000-0001-7266-2503","observed_orcids":["https://orcid.org/0000-0001-7266-2503"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Mohammed Ali","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5021463492","display_name":"Michal Yacobovitz","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Michal Yacobovitz","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5109099819","display_name":"Gili Solomon","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Gili Solomon","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5059252348","display_name":"Shay Reicher","orcid":"https://orcid.org/0000-0002-0858-4317","observed_orcids":["https://orcid.org/0000-0002-0858-4317"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Shay Reicher","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5023676631","display_name":"Jessica L. Lynch","orcid":"https://orcid.org/0000-0003-2015-9986","observed_orcids":["https://orcid.org/0000-0003-2015-9986"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Jessica L. Lynch","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5065040805","display_name":"Zamir Halpern","orcid":"https://orcid.org/0000-0003-0195-6138","observed_orcids":["https://orcid.org/0000-0003-0195-6138"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Zamir Halpern","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5054959155","display_name":"William A. Banks","orcid":"https://orcid.org/0000-0002-0496-3619","observed_orcids":["https://orcid.org/0000-0002-0496-3619"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"William A. Banks","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5022415049","display_name":"Arieh Gertler","orcid":"https://orcid.org/0000-0002-3451-1306","observed_orcids":["https://orcid.org/0000-0002-3451-1306"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Arieh Gertler","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":{"value":3750,"currency":"USD","value_usd":3750},"apc_paid":null,"fwci":0.1496,"has_fulltext":false,"cited_by_count":5,"citation_normalized_percentile":{"value":0.55281615,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":89,"max":95},"biblio":{"volume":"94","issue":"6","first_page":"2209","last_page":"2209"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10489","display_name":"Regulation of Appetite and Obesity","score":0.9990000128746033,"subfield":{"id":"https://openalex.org/subfields/2807","display_name":"Endocrine and Autonomic Systems"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10489","display_name":"Regulation of Appetite and Obesity","score":0.9990000128746033,"subfield":{"id":"https://openalex.org/subfields/2807","display_name":"Endocrine and Autonomic Systems"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10528","display_name":"Adipokines, Inflammation, and Metabolic Diseases","score":0.0006000000284984708,"subfield":{"id":"https://openalex.org/subfields/2713","display_name":"Epidemiology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10960","display_name":"Hypothalamic control of reproductive hormones","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/2743","display_name":"Reproductive Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/leptin","display_name":"leptin","score":0.6909999847412109},{"id":"https://openalex.org/keywords/leptin-antagonist","display_name":"leptin antagonist","score":0.8299999833106995},{"id":"https://openalex.org/keywords/pegylation","display_name":"PEGylation","score":0.9660000205039978},{"id":"https://openalex.org/keywords/orexigenic-effect","display_name":"orexigenic effect","score":0.8199999928474426},{"id":"https://openalex.org/keywords/food-consumption","display_name":"dietary intake","score":0.859000027179718},{"id":"https://openalex.org/keywords/weight-gain","display_name":"weight gain","score":0.925000011920929},{"id":"https://openalex.org/keywords/leptin-deficiency","display_name":"leptin deficiency","score":0.890999972820282},{"id":"https://openalex.org/keywords/blood-brain-barrier","display_name":"blood-brain barrier","score":0.828000009059906},{"id":"https://openalex.org/keywords/leptin-transport","display_name":"leptin transport","score":0.859000027179718},{"id":"https://openalex.org/keywords/arcuate-nucleus","display_name":"arcuate nucleus","score":0.9940000176429749},{"id":"https://openalex.org/keywords/adipokines","display_name":"adipokines","score":0.7260000109672546},{"id":"https://openalex.org/keywords/cachexia","display_name":"cachexia","score":0.8019999861717224},{"id":"https://openalex.org/keywords/drug-bioavailability","display_name":"drug bioavailability","score":0.5490000247955322},{"id":"https://openalex.org/keywords/circulating-half-life","display_name":"serum half-life","score":0.5929999947547913}],"concepts":[{"id":"https://openalex.org/C2776885963","wikidata":"https://www.wikidata.org/wiki/Q245204","display_name":"Antagonist","level":3,"score":0.7421113848686218},{"id":"https://openalex.org/C2777205416","wikidata":"https://www.wikidata.org/wiki/Q433807","display_name":"Orexigenic","level":5,"score":0.6828848123550415},{"id":"https://openalex.org/C89611455","wikidata":"https://www.wikidata.org/wiki/Q6804646","display_name":"Mechanism (biology)","level":2,"score":0.6538127660751343},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.5340444445610046},{"id":"https://openalex.org/C2780613262","wikidata":"https://www.wikidata.org/wiki/Q223739","display_name":"Leptin","level":3,"score":0.5166195034980774},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.37154272198677063},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.32617732882499695},{"id":"https://openalex.org/C134018914","wikidata":"https://www.wikidata.org/wiki/Q162606","display_name":"Endocrinology","level":1,"score":0.3064625859260559},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.3058139383792877},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.11436808109283447},{"id":"https://openalex.org/C118303440","wikidata":"https://www.wikidata.org/wiki/Q419968","display_name":"Neuropeptide","level":3,"score":0.0790475606918335},{"id":"https://openalex.org/C138885662","wikidata":"https://www.wikidata.org/wiki/Q5891","display_name":"Philosophy","level":0,"score":0.054406166076660156},{"id":"https://openalex.org/C93984277","wikidata":"https://www.wikidata.org/wiki/Q24782073","display_name":"Neuropeptide Y receptor","level":4,"score":0.0},{"id":"https://openalex.org/C111472728","wikidata":"https://www.wikidata.org/wiki/Q9471","display_name":"Epistemology","level":1,"score":0.0},{"id":"https://openalex.org/C511355011","wikidata":"https://www.wikidata.org/wiki/Q12174","display_name":"Obesity","level":2,"score":0.0}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1210/jcem.94.6.9996","doi":"https://doi.org/10.1210/jcem.94.6.9996","is_oa":false,"landing_page_url":"https://doi.org/10.1210/jcem.94.6.9996","pdf_url":null,"source":{"id":"https://openalex.org/S205775358","display_name":"The Journal of Clinical Endocrinology & Metabolism","issn_l":"0021-972X","issn":["0021-972X","1945-7197"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-class-a","anvur-scientific","cwts-core","dongbi-b","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310311648","host_organization_name":"Oxford University Press","host_organization_lineage":["https://openalex.org/P4310311648","https://openalex.org/P4310311647"],"host_organization_lineage_names":["Oxford University Press","University of Oxford"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"The Journal of Clinical Endocrinology & Metabolism","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"score":1.0,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W4243202565","https://openalex.org/W2953492532","https://openalex.org/W2043730876","https://openalex.org/W1975002723","https://openalex.org/W2016446272","https://openalex.org/W2157413586","https://openalex.org/W1989037958","https://openalex.org/W2469638093","https://openalex.org/W2030065837","https://openalex.org/W2048137214"],"abstract_inverted_index":{"Leptin,":[0],"a":[1,5,13,41,49,60,94,168,175,205],"pleiotropic":[2],"adipokine,":[3],"is":[4,25],"central":[6,141,180],"regulator":[7],"of":[8,53,59,71,85,133,139,152,154,194,210],"appetite":[9],"and":[10,12,83,96,122,181,198,201],"weight":[11,22,103],"key":[14],"immunomodulatory":[15],"protein.":[16],"Although":[17],"inborn":[18],"leptin":[19,29,44,54,73,134,142,156,183,195],"deficiency":[20,30,55,143],"causes":[21],"gain,":[23],"it":[24],"unclear":[26],"whether":[27],"induced":[28],"in":[31,56,79,99,116,190,196],"adult":[32],"wild-type":[33],"animals":[34],"would":[35],"be":[36,147,188],"orexigenic.":[37],"Previous":[38],"work":[39],"with":[40,102,113,161],"potent":[42],"competitive":[43],"antagonist":[45,74,92,135],"did":[46],"not":[47],"induce":[48],"true":[50],"metabolic":[51,197],"state":[52],"mice":[57],"because":[58],"short":[61],"circulating":[62,155],"half-life.":[63],"In":[64],"this":[65],"study,":[66],"we":[67,173],"increased":[68,81],"the":[69,72,90,110,117,158,164,192,208],"half-life":[70],"by":[75,150],"pegylation,":[76],"which":[77],"resulted":[78],"significantly":[80],"bioavailability":[82],"retaining":[84],"antagonistic":[86],"activity.":[87],"Mice":[88],"administered":[89],"pegylated":[91],"showed":[93],"rapid":[95],"dramatic":[97],"increase":[98],"food":[100],"intake":[101],"gain.":[104],"Resulting":[105],"fat":[106],"was":[107,144],"confined":[108],"to":[109,146],"mesenteric":[111],"region":[112],"no":[114],"accumulation":[115],"liver.":[118],"Serum":[119],"cholesterol,":[120],"triglyceride,":[121],"hepatic":[123],"aminotransferases":[124],"remained":[125],"unaffected.":[126],"Weight":[127],"changes":[128],"were":[129],"reversible":[130],"on":[131],"cessation":[132],"treatment.":[136],"The":[137],"mechanism":[138],"severe":[140],"found":[145],"primarily":[148],"caused":[149],"blockade":[151],"transport":[153],"across":[157],"blood-brain":[159],"barrier":[160],"antagonisms":[162],"at":[163],"arcuate":[165],"nucleus":[166],"playing":[167],"more":[169],"minor":[170],"role.":[171],"Altogether":[172],"introduce":[174],"novel":[176],"compound":[177,186],"that":[178],"induces":[179],"peripheral":[182],"deficiency.":[184],"This":[185],"should":[187],"useful":[189],"exploring":[191],"involvement":[193],"immune":[199],"processes":[200],"could":[202],"serve":[203],"as":[204],"therapeutic":[206],"for":[207],"treatment":[209],"cachexia.":[211]},"counts_by_year":[{"year":2021,"cited_by_count":2},{"year":2015,"cited_by_count":1},{"year":2014,"cited_by_count":1}],"updated_date":"2026-10-29T09:56:32.521200","created_date":"2022-05-12T00:00:00"}